Skip to main content
M

Many Bright Ideas Technologies Inc. — Investor Relations & Filings

Ticker · MBI.H TSXV Professional, scientific and technical activities
Filings indexed 83 across all filing types
Latest filing 2023-07-19 Regulatory Filings
Country CA Canada
Listing TSXV MBI.H

About Many Bright Ideas Technologies Inc.

https://www.medbiogene.com/

Many Bright Ideas Technologies Inc. is a technology commercialization company focused on the acquisition, development, and commercialization of intellectual property across various industrial sectors, emphasizing alternative non-medical technologies. The company maintains a significant legacy interest in the life sciences domain. Its primary licensed asset is GeneFx® Lung, a proprietary gene expression-based diagnostic test. GeneFx® Lung is designed to assist in personalized treatment decisions for patients with early-stage non-small-cell lung cancer (NSCLC) by predicting mortality risk and identifying those who may benefit from adjuvant chemotherapy. Exclusive global rights for the development and commercialization of GeneFx® Lung are held by Precision Therapeutics, Inc.

Recent filings

Filing Released Lang Actions
Notice of meeting - English.pdf
Regulatory Filings
2023-07-19 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2023-04-21 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2023-04-21 English
Annual MD&A - English.pdf
Regulatory Filings
2023-04-21 English
Audited annual financial statements – English.pdf
Regulatory Filings
2023-04-21 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2023-04-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.